Genome-wide CRISPR screen identifies PRC2 and KMT2D-COMPASS as regulators of distinct EMT trajectories that contribute differentially to metastasisYun Zhang, Robert A. Weinberg, Joana Liu Donaher et al.|Nature Cell Biology|2022Cited by 130
Exploiting epigenetic targets to overcome taxane resistance in prostate cancerBuse Cevatemre, Ceyda Açılan, İpek Bulut et al.|Cell Death and Disease|2024Cited by 20
Chromatin-focused genetic and chemical screens identify BRPF1 as a targetable vulnerability in Taxol-resistant triple-negative breast cancerOzlem Yedier-Bayram, Tugba Bagcı-Önder, Buse Cevatemre et al.|Experimental & Molecular Medicine|2025Cited by 4
Exploiting Epigenetic Targets to Overcome Taxane Resistance in Prostate CancerBuse Cevatemre, Ceyda Açılan, İpek Bulut et al.|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 0
Abstract PR05: Loss of PRC2 or KMT2D-COMPASS generates two quasi-mesenchymal cell states with distinct metastatic abilitiesYun Zhang, Robert A. Weinberg, Joana Liu Donaher et al.|Cancer Research|2020Cited by 0